Using radiotherapy to improve PFS for stage IA nodular lymphocyte-predominant Hodgkin lymphoma
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2025-06-24
Просмотров: 203
Описание:
Jamie Flerlage, MD, MS, University of Rochester, Rochester, NY, comments on the impact of radiation therapy on progression-free survival (PFS) in patients with stage IA nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). Dr Flerlage highlights that localized radiation therapy can improve PFS by over 20% in this patient population and emphasizes the importance of individualized decision-making for each patient, taking into account the specific site, risks, and benefits.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
